Company Information

Dr Tony Atkinson BSc, PhD, FioN, FIIBiol

Tony Atkinson co-founded Kymed in the mid 1990’s, which was merged with Enzacta Plc on the Ofex Stock Exchange in 2000 as Enact Pharma Plc. Moving from CSO to CEO in 2001 he was key in the merger of Enact into the main London Stock Exchange listed biopharmaceutical company Protherics Plc in 2003 of whom he became a main Board Director and CSO. In 2004 he co-founded Morvus Technology Ltd, a pharmaceutical company and NanoMor Biomedical Ltd, a bionanotechnology company both spin-outs from Protherics plc and is currently Chairman of both. Tony is also a Director of a number of companies including the AIM listed Biofusion plc, Lab21 Ltd, Eden Biopharma Ltd and TMO Renewables Ltd. As the co-founder of TMI Ltd he has a corporate Directorship and shareholding in a number of early stage companies.

Back

Board of Directors | Senior Management